CLINICAL_TRIALS trial_result · 2025-07-01

Clinical Trial Update: Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN) [Phase 2]

Phase 2 trial evaluating VX-548 for painful diabetic peripheral neuropathy has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2025-07-01